As a result, the identification of five prospective gene biomarkers that are differently expressed in AD, such as SELE, TGFβ1, MYH11, ITGB1, and CXCR4, offers possibilities for clinically diagnostic biomarkers that can identify AD patients. The gene discussed is CXCR4; the disease is Alzheimer disease.